Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating to Target (T2T) for Patients With Rheumatoid Arthritis in a US Population: Outcomes and Feasibility

NCT01407419 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.

NCT NCT01407419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01407419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating to Target (T2T) for Patients With Rheumatoid Arthritis in a US Population: Outcomes and Feasibility
Lead sponsor
CorEvitas
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2014
Enrollment
538 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis